These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9331707)

  • 1. Novel superantigens from streptococcal toxic shock syndrome Streptococcus pyogenes isolates.
    Newton D; Norrby-Teglund A; McGeer A; Low DE; Schlievert PM; Kotb M
    Adv Exp Med Biol; 1997; 418():525-9. PubMed ID: 9331707
    [No Abstract]   [Full Text] [Related]  

  • 2. Cases of streptococcal toxic shock syndrome in Germany since 1989, toxin (mitogen) expression, content of toxin genes and relation to M-serotypes.
    Günther E; Gerlach D; Reichardt W; Ozegowski JH; Zigann T
    Adv Exp Med Biol; 1997; 418():245-8. PubMed ID: 9331643
    [No Abstract]   [Full Text] [Related]  

  • 3. Severe group A streptococcal infections.
    Shulman ST
    Crit Care Med; 1993 Sep; 21(9 Suppl):S314-5. PubMed ID: 8365202
    [No Abstract]   [Full Text] [Related]  

  • 4. Serotype, biotype, pyrogenic exotoxin, streptolysin O and exoenzyme patterns of invasive Streptococcus pyogenes isolates from patients with toxin shock syndrome, bacteremia and other severe infections.
    Müller-Alouf H; Geoffroy C; Geslin P; Bouvet A; Felten A; Günther E; Ozegowski JH; Reichardt W; Alouf JE
    Adv Exp Med Biol; 1997; 418():241-3. PubMed ID: 9331642
    [No Abstract]   [Full Text] [Related]  

  • 5. Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project.
    Watanabe-Ohnishi R; Low DE; McGeer A; Stevens DL; Schlievert PM; Newton D; Schwartz B; Kreiswirth B; Kotb M
    J Infect Dis; 1995 Jan; 171(1):74-84. PubMed ID: 7798684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of group A serotypes and streptococcal pyrogenic exotoxin gene types isolated from blood in Canada.
    Forwick BA; Lovgren M; Chui LW; Talbot JA
    Adv Exp Med Biol; 1997; 418():237-9. PubMed ID: 9331641
    [No Abstract]   [Full Text] [Related]  

  • 7. Streptococcal pyrogenic exotoxin A, streptolysin O, exoenzymes, serotype and biotype profiles of Streptococcus pyogenes isolates from patients with toxic shock syndrome and other severe infections.
    Müller-Alouf H; Geoffroy C; Geslin P; Bouvet A; Felten A; Günther E; Ozegowski JH; Alouf JE
    Zentralbl Bakteriol; 1997 Oct; 286(3):421-33. PubMed ID: 9361388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of Streptococcus pyogenes serotype M1 and M3 isolates from patients in Japan from 1981 to 1997.
    Murase T; Suzuki R; Osawa R; Yamai S
    J Clin Microbiol; 1999 Dec; 37(12):4131-4. PubMed ID: 10565944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superantigenic activity produced by group A streptococcal isolates is neutralized by plasma from IVIG-treated streptococcal toxic shock syndrome patients.
    Norrby-Teglund A; Low DE; McGeer A; Kotb M
    Adv Exp Med Biol; 1997; 418():563-6. PubMed ID: 9331714
    [No Abstract]   [Full Text] [Related]  

  • 10. Application of emm gene sequencing and T antigen serology for typing group A streptococcal systemic isolates. Survey of random and outbreak-related isolates.
    Beall B; Facklam R; Hoenes T; Schwartz B
    Adv Exp Med Biol; 1997; 418():307-11. PubMed ID: 9331658
    [No Abstract]   [Full Text] [Related]  

  • 11. Changing prevalent T serotypes and emm genotypes of Streptococcus pyogenes isolates from streptococcal toxic shock-like syndrome (TSLS) patients in Japan.
    Ikebe T; Murai N; Endo M; Okuno R; Murayama S; Saitoh K; Yamai S; Suzuki R; Isobe J; Tanaka D; Katsukawa C; Tamaru A; Katayama A; Fujinaga Y; Hoashi K; Ishikawa J; Watanabe H;
    Epidemiol Infect; 2003 Jun; 130(3):569-72. PubMed ID: 12825743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrogenic toxin type A (ETA): epidemiological analysis of gene distribution and protein formation in clinical Streptococcus pyogenes strains causing scarlet fever and the streptococcal toxic shock-like syndrome (TSLS).
    Reichardt W; Müller-Alouf H; Köhler W
    Zentralbl Bakteriol; 1993 Jun; 279(2):283-93. PubMed ID: 8219499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotyping of Streptococcus pyogenes isolated from common and severe invasive infections in Japan, 1990-5: implication of the T3 serotype strain-expansion in TSLS. The Working Group for Group A Streptococci in Japan.
    Inagaki Y; Konda T; Murayama S; Yamai S; Matsushima A; Gyobu Y; Tanaka D; Tamaru A; Katsukawa C; Katayama A; Tomita M; Fuchi Y; Hoashi K; Watanabe H
    Epidemiol Infect; 1997 Aug; 119(1):41-8. PubMed ID: 9287942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrogenic toxins A, B and C: occurrence of the genes and exotoxin formation from clinical Streptococcus pyogenes strains associated with streptococcal toxic shock-like syndrome.
    Reichardt W; Müller-Alouf H; Alouf JE; Köhler W
    FEMS Microbiol Lett; 1992 Dec; 100(1-3):313-22. PubMed ID: 1478466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogenic factors from group G streptococci associated with scarlet fever and streptococcal toxic shock syndrome.
    Assimacopoulos AP; Stoehr JA; Schlievert PM
    Adv Exp Med Biol; 1997; 418():109-14. PubMed ID: 9331611
    [No Abstract]   [Full Text] [Related]  

  • 16. Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome.
    Eriksson BK; Andersson J; Holm SE; Norgren M
    J Infect Dis; 1999 Aug; 180(2):410-8. PubMed ID: 10395857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive and noninvasive group A streptococcal isolates with different speA alleles in The Netherlands: genetic relatedness and production of pyrogenic exotoxins A and B.
    Mascini EM; Jansze M; Schouls LM; Fluit AC; Verhoef J; van Dijk H
    J Clin Microbiol; 1999 Nov; 37(11):3469-74. PubMed ID: 10523536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual infections with Staphylococcus aureus and Streptococcus pyogenes causing toxic shock syndrome. Possible synergistic effects of toxic shock syndrome toxin 1 and streptococcal pyrogenic exotoxin C.
    Smith RJ; Schlievert PM; Himelright IM; Baddour LM
    Diagn Microbiol Infect Dis; 1994 Aug; 19(4):245-7. PubMed ID: 7851088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of streptococcal pyrogenic exotoxins in streptococcal toxic shock-like syndrome and other severe invasive infections.
    Musser JM
    Pediatr Ann; 1992 Dec; 21(12):821-2, 825-8. PubMed ID: 1480436
    [No Abstract]   [Full Text] [Related]  

  • 20. Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome.
    Darenberg J; Söderquist B; Normark BH; Norrby-Teglund A
    Clin Infect Dis; 2004 Mar; 38(6):836-42. PubMed ID: 14999628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.